Journal of Luminescence | Cas: 5805-39-0 was involved in experiment

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Name: 2-(1H-Benzo[d]imidazol-2-yl)aniline) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Nawrot, I.;Czerwinska, Katarzyna;Machura, B.;Kruszynski, R. published 《Synthesis, structural diversity and luminescent properties of cadmium(II) coordination assemblies with 2-(2-aminophenyl)-1H-benzimidazole and pseudohalide ions》 in 2017. The article was appeared in 《Journal of Luminescence》. They have made some progress in their research.Name: 2-(1H-Benzo[d]imidazol-2-yl)aniline The article mentions the following:

A systematic investigation of Cd(II)-(apbim)-X systems (apbim=2-(2-aminophenyl)-1H-benzimidazole and X=N3,SCN and N(NC)2) was conducted, and the following cadmium(II) coordination compounds [Cd(N3)2(apbim)]n•nMeOH (1), [Cd(SCN)2(apbim)]n•nMeOH (2), [Cd(dca)(apbim)2]n•n(NO3) (3), [Cd(SCN)2(apbim)2] (4) and [Cd(dca)2(apbim)2]•H2O (5) were successfully synthesized and characterized by single-crystal diffraction, X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC) anal. and IR spectroscopy. The luminescent properties of 2-(2-aminophenyl)-1H-benzimidazole and cadmium(II) coordination compounds were studied in solution (4 and 5) and solid state (1-5). The studies revealed that the solid state architecture and solid state photoluminescent properties of the Cd(II)-apbim-X systems (X=N3, NCS and dca) are strongly influenced by intermol. interactions. To complete the study, the researchers used 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) .

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Name: 2-(1H-Benzo[d]imidazol-2-yl)aniline) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Cas: 5805-39-0 | Meng, Xiang-He et al. made new progress in 2021

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Electric Literature of C13H11N3) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Electric Literature of C13H11N3In 2021, Meng, Xiang-He;Wu, Dan-Ni;Zhang, Yu-Jia;Zhao, Yu-Long published 《PPTS-Catalyzed Bicyclization Reaction of 2-Isocyanobenzaldehydes with Various Amines: Synthesis of Diverse Fused Quinazolines》. 《Advanced Synthesis & Catalysis》published the findings. The article contains the following contents:

A PPTS (pyridinium p-toluenesulfonate)-catalyzed bicyclization reaction of 2-isocyanobenzaldehydes 2-NC-4-R-5-R1C6H2CHO (R = H, Br, OMe; R1 = H, Cl, F, OMe) as 1,5-dielectrophiles with various amines R2NH2 (R2 = 3-hydroxypropyl, 2-amino-4,5-difluorophenyl, 2-(1H-pyrrol-1-yl)benzen-1-yl, etc.) has been developed. The reaction not only provides a simple and efficient strategy for the assembly of structurally diverse fused quinazoline derivatives e.g., I from readily available substrates under metal-free and mild conditions in a single step with only water and hydrogen as the byproducts, but also opens the way to the application of o-formyl arylisocyanides in the synthesis of nitrogen-containing heterocycles e.g., I. And 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) was used in the research process.

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Electric Literature of C13H11N3) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Voskoboinik, Olexii Yu. et al. published new progress in experiments with the help of cas: 5805-39-0

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Quality Control of 2-(1H-Benzo[d]imidazol-2-yl)aniline) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Voskoboinik, Olexii Yu.;Stavytskyi, Viktor V.;Antypenko, Oleksii M.;Kazunin, Maksym S.;Kravtsov, Dmytro V.;Shishkina, Svetlana V.;Kovalenkoa, Sergiy I. published 《Synthesis and structure of pyrido[1,2-a]quinazoline condensed derivatives》. The research results were published in《Synthetic Communications》 in 2020.Quality Control of 2-(1H-Benzo[d]imidazol-2-yl)aniline The article conveys some information:

Present manuscript describes the synthesis and mol. structure features of novel condensed pyrido[1,2-a]quinazolines e.g., I. The above mentioned compounds e.g., I were synthesized via condensation of 2-[azolyl-(azinyl-)]anilines 2-R-4-R1-C6H3NH2 (R = 1H-1,3-benzodiazol-2-yl, 3-methyl-1H-1,2,4-triazol-5-yl, 1H-1,2,3,4-tetrazol-5-yl, 5-oxo-6-phenyl-2,5-dihydro-1,2,4-triazin-3-yl, etc.; R1 = H, Br) with 5-oxohexanoic acid. The tandem condensation intermediates e.g., II were isolated and cyclized under various conditions. The structures of synthesized compounds e.g., I were confirmed by LC-MS and NMR-spectroscopy. The existence of the e.g., I mols. as superposition of two resonance structures was detected by the X-Ray anal. To complete the study, the researchers used 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) .

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Quality Control of 2-(1H-Benzo[d]imidazol-2-yl)aniline) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Explore more uses of cas: 5805-39-0 | Catalysis Communications

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 COA of Formula: C13H11N3) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

COA of Formula: C13H11N3《I2/TBHP promoted isocyanide insertion cyclization reaction for the synthesis of quinazolin fused benzoimidazole as a selective methanol detection probe》 was published in 2021. The authors were Ahmadi, Fereshteh;Ahmadi, Nafiseh;Balmohammadi, Yaser;Naimi-Jamal, Mohammad Reza;Bazgir, Ayoob, and the article was included in《Catalysis Communications》. The author mentioned the following in the article:

An efficient I2/TBHP promoted isocyanide insertion cyclization reaction for the synthesis of quinazoline-fused benzoimidazoles was reported. The synthesized compounds have a unique potential to use as a selective solvatochromic fluorescence probe for methanol detection from other solvents, especially EtOH. Introducing a simple one-step method and using a more acceptable iodine mol. instead of expensive transition metal catalysts are the most important advantages of this strategy. To complete the study, the researchers used 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) .

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 COA of Formula: C13H11N3) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Cas: 5805-39-0 | Pandey, Rampalpublished an article in 2017

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Product Details of 5805-39-0) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Pandey, Rampal;Mehes, Gabor;Kumar, Ashish;Singh, Roop Shikha;Kumar, Amit;Adachi, Chihaya;Pandey, Daya Shankar published 《Strong luminescence behavior of mono- and dimeric imidazoquinazolines: Swift OLED degradation under electrical current》 in 2017. The article was appeared in 《Journal of Luminescence》. They have made some progress in their research.Product Details of 5805-39-0 The article mentions the following:

Design and synthesis of novel mono- and dimeric quinazoline derivatives (+)-6-methyl-6-pyridin-2-yl-5,6-dihydrobenzo[4,5]imidazo[1,2-c]quinazoline (1) and (+)-6-[(6-methyl-5,6-dihydrobenzo-[4,5]imidazo[1,2-c]quinazolin-6-yl)-pyridin-2-yl]-6-methyl-5,6-dihydro-benzo-[4,5]imidazo-[1,2-c]quinazoline (2) have been described. Both 1 and 2 have been characterized by elemental analyses, FT-IR, 1H and 13C NMR, HRMS spectroscopic studies and their structures authenticated by X-ray single crystal analyses. Photophys. properties of these compounds have been studied by UV/VIS absorption and fluorescence spectroscopy and transient photoluminescence anal. in solution, powder, and non-doped (neat) and doped vacuum-deposited films. A broad emission spectrum spanning most of the visible range and good thermal stability indicated promising application of 1 and 2 as OLED emitters. Unfortunately, under current flow we observed rapid device degradation, presumably to be related to free -NH moiety in these compounds And 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) was used in the research process.

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Product Details of 5805-39-0) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Cas: 5805-39-0 | Liang, Danqing et al. made new progress in 2020

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Recommanded Product: 5805-39-0) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Liang, Danqing;Ming, Jin;Li, Li;Mohammadnia, Majid published 《Preparation and characterization of Cu supported on 2-(1H-benzo[d]imidazol-2-yl)aniline-functionalized Fe3O4 nanoparticles as a novel magnetic catalyst for Ullmann and Suzuki cross-coupling reactions》. The research results were published in《Applied Organometallic Chemistry》 in 2020.Recommanded Product: 5805-39-0 The article conveys some information:

Copper supported on 2-(1H-benzo[d]imidazol-2-yl)aniline (BIA)-functionalized Fe3O4 nanoparticles (Cu-BIA-Si-Fe3O4) as a novel magnetic catalyst was designed and used for the synthesis of new products via Ullmann and Suzuki cross-coupling reactions. The Ullmann reaction was performed by mixing arylboronic acid with aniline derivatives in dimethylsulfoxide solvent. Also, diaryls were synthesized via Suzuki C-C reactions between aryl halides and phenylboronic acid in the same solvent. The prepared materials and catalyst were characterized with various anal. techniques. The Cu-BIA-Si-Fe3O4 catalyst demonstrated catalytic efficiency with good to excellent yields for both types of reactions in comparison with com. palladium catalysts. Also, the catalyst could be recovered by a simple filtration and retained its activity even after several cycles. To complete the study, the researchers used 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) .

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Recommanded Product: 5805-39-0) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Shree, Ganesan Jeya et al. published new experimental results with the assistance of cas: 5805-39-0

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Name: 2-(1H-Benzo[d]imidazol-2-yl)aniline) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Shree, Ganesan Jeya;Sivaraman, Gandhi;Siva, Ayyanar;Chellappa, Duraisamy published 《Anthracene- and pyrene-bearing imidazoles as turn-on fluorescent chemosensor for aluminum ion in living cells》 in 2019. The article was appeared in 《Dyes and Pigments》. They have made some progress in their research.Name: 2-(1H-Benzo[d]imidazol-2-yl)aniline The article mentions the following:

A newly designed 2-(2-Aminophenyl)-1H-benzimidazole integrated anthracene/pyrene derivatives as efficient chemosensors were synthesized. The probes N-(anthracen-9-ylmethylene)-2-(1H-benzo[d]imidazol-2-yl)aniline (ANP) and N-(pyren-1-ylmethylene)-2-(1H-benzo[d]imidazol-2-yl)-aniline (PYP) exhibited high selectivity and sensitivity towards Al3+ ion over other interfering and competing cations in aqueous solution Job’s plot anal. reveals that the interaction of ANP/PYP with Al3+ was 1:1 binding stoichiometry. The detection limit of probes ANP and PYP for Al3+ ions are 1.85 × 10-7 M and 1.08 × 10-7 M, resp. The DFT/TD-DFT calculations have also been revealed that the ICT mechanism is responsible for the observed photophys. changes. Moreover, the probes ANP and PYP were applicable to image intracellular Al3+ ions in living cells via confocal fluorescence microscopy technique. The experimental procedure involved many compounds, such as 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) .

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Name: 2-(1H-Benzo[d]imidazol-2-yl)aniline) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Korrapati, Suresh Babu et al. published new progress in experiments with the help of cas: 5805-39-0

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Quality Control of 2-(1H-Benzo[d]imidazol-2-yl)aniline) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Korrapati, Suresh Babu;Yedla, Poornachandra;Pillai, Girinath G.;Mohammad, Faruq;Ch., Venkata Ramana Reddy;Bhamidipati, Pranav;Amanchy, Ramars;Syed, Riyaz;Kamal, Ahmed published 《In-silico driven design and development of spirobenzimidazo-quinazolines as potential DNA gyrase inhibitors》. The research results were published in《Biomedicine & Pharmacotherapy》 in 2021.Quality Control of 2-(1H-Benzo[d]imidazol-2-yl)aniline The article conveys some information:

DNA gyrase and Topoisomerase IV are promising antibacterial drug targets as they regulate bacterial DNA replication and topol. In a quest for novel DNA topoisomerase inhibitors, a multidisciplinary approach was adopted that involves computational prediction of binding sites and mol. modeling followed by green synthesis and biol. evaluation of antibacterial activity of spirobenzimidazo quinazolines derivatives Using basic quantum chem. principles, we evaluated spirobenzimidazo quinazolines derivatives with their pharmacokinetic profiles. Based on the results of the aforesaid in-silico studies, we synthesized a series of titled compounds using green synthetic methodol. that were validated as potential antimicrobial agents. Quantum chemoinformatics based predicted activity for the synthesized compounds 9b, 9c, and 9j was concomitant with biol. evaluation of broadspectrum antibacterial activity. Biol. evaluation revealed that inhibition of biofilm formation was due to their potential antibacterial activity. We believe that the novel spirobenzimidazo quinazolines have the potential to be alternatives to aminocoumarins and classical quinazolines upon detailed target specific biol. studies. The experimental procedure involved many compounds, such as 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) .

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Quality Control of 2-(1H-Benzo[d]imidazol-2-yl)aniline) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Application of cas: 5805-39-0 | Hu, Wangqin et al. published an article in 2019

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 HPLC of Formula: 5805-39-0) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

HPLC of Formula: 5805-39-0In 2019, Hu, Wangqin;Yang, Wen;Gong, Tingfeng;Zhou, Weiqun;Zhang, Yuhan published 《Multi-stimuli responsive properties switch by intra- and inter-molecular charge transfer constructed from triphenylamine derivative》. 《CrystEngComm》published the findings. The article contains the following contents:

Combining triphenylamine (TPA) and 2-(1H-benzo[d]imidazol-2-yl) aniline (BI), a typical fluorescent dye, TPA-BI, was designed and synthesized. The photo-phys. properties of this compound were investigated both in solution and the solid state. TPA-BI showed a strong AIEE effect and its relative fluorescence quantum yield (φf) was up to 63.4% in the aggregation state. The tunable fluorescence phenomenon by the MCF effect was observed between the amorphous (bluish violet) and crystalline (green) states, and the absolute φf was determined to be 56.2% and 21.9%, resp., by the integral sphere method. Meanwhile, pH titration experiments exhibited the tunable fluorescence phenomenon in different pH solutions Thus, TPA-BI could also be used as a fluorescent switch from green to bluish-violet based on its response to volatile acidic and alk. organic compounds in the solid state repeatedly without fatigue and destruction under UV illumination (365 nm), which can be explained by the reversible transformation by protonation and deprotonation. The protonation process was further confirmed in detail by 1HNMR titration experiments D. functional theory (DFT) and time-dependent d. functional theory (TD-DFT) were used to predict the multi-stimuli responsive fluorescence properties. And 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) was used in the research process.

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 HPLC of Formula: 5805-39-0) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

Learn more about cas: 5805-39-0 | Chemistry Central Journal 2018

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Synthetic Route of C13H11N3) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Hasan, Hiba Ali;Abdulmalek, Emilia;Abdul Rahman, Mohd Basyaruddin;Shaari, Khozirah Binti;Yamin, Bohari Mohd.;Chan, Kim Wei published 《Microwave synthesis, crystal structure, antioxidant, and antimicrobial study of new 6-heptyl-5,6-dihydrobenzo[4,5]imidazo[1,2-c] quinazoline compound》 in 2018. The article was appeared in 《Chemistry Central Journal》. They have made some progress in their research.Synthetic Route of C13H11N3 The article mentions the following:

A comparative study between two methods, (microwave-assisted and conventional heating approaches), was performed to synthesize a new quinazoline derivative from 2-(2-aminophenyl)-1H-benzimidazole and octanal to produce 6-heptyl-5,6-dihydrobenzo[4,5]imidazo[1,2-c]quinazoline (OCT). The compound was characterised using FTIR, 1H and 13C NMR, DIMS, as well as X-ray crystallog. The most significant peak in the 13C NMR spectrum is C-7 at 65.5 ppm which confirmed the cyclization process. Crystal structure anal. revealed that the mol. growed in the monoclinic crystal system P21/n space group and stabilized by an intermol. hydrogen bond between the N1-H1A···N3 atoms. The crystal packing anal. showed that the mol. adopts zig-zag one dimensional chains. Fluorescence study of OCT revealed that it produced blue light when expose to UV-light and its quantum yield equal to 26%. Antioxidant activity, which included DPPH· and ABTS·+ assays was also performed and statistical anal. was achieved via a paired T-test using Minitab 16 software with P < 0.05. Also, the antimicrobial assay against two Gram-pos., two Gram-neg., and one fungus was screened for these derivatives Using microwave to synthesize OCT have drastically reduced reaction time, and increased yield. OCT showed good antioxidant activity in one of the tests and moderate antimicrobial activity. The experimental procedure involved many compounds, such as 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) .

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Synthetic Route of C13H11N3) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem